I
Insulet
Sustainability Report and Carbon Intensity Rankings
Is Insulet doing their part?
Their DitchCarbon score is 41
Insulet has a DitchCarbon Score of 41 out of 100, indicating moderate performance in sustainability measures. This score reflects the company’s current carbon intensity, suggesting there is significant room for improvement in reducing emissions. A higher score would denote stronger efforts to lower carbon intensity and enhance overall sustainability.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Insulet is a company in the services sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
Insulet, located in the United States, operates in a region with a low carbon intensity rating. This suggests that the company’s sustainability efforts are positively influenced by the country’s relatively lower reliance on carbon-intensive energy sources.
Unlock 30+ emissions data points on Insulet
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Insulet
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
2.85%
...this company is doing 2.85% worse in emissions than the industry average.
Insulet Corporation, founded in 2000 and headquartered in Billerica, Massachusetts, operates within the medical device industry. The company specializes in the development and distribution of the Omnipod® Insulin Management System, designed to improve the quality of life for individuals with insulin-dependent diabetes. In addition to diabetes management solutions, Insulet partners with pharmaceutical and biotech firms to adapt its technology for various subcutaneous drug delivery applications.
emission intelligence's platform recommendations for Insulet
Insulet should undertake a thorough inventory of all Scope 1 emissions sources to identify and mitigate direct greenhouse gas emissions, which could potentially reduce their emissions by 15%.
Good news, Insulet has set science-based climate targets
Insulet has established Science Based Targets initiative (SBTi) commitments to significantly reduce their greenhouse gas emissions from company operations, which include both direct emissions and indirect emissions from purchased energy. These targets align with the global effort to limit temperature rise to well below 2°C above pre-industrial levels.
Participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.